Delivery Order SPE2DB24D2205-SPE2DB25FEAWN
Award Date
4/11/25
Potential Completion Date
4/14/25
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,260, is a delivery order for the medication Mounjaro 7.5 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of November 15, 2024 and is a firm fixed price contract. AmerisourceBergen Drug Corp is the prime contractor, and the contract was not designated with a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,189.22, is for the delivery of the drug Mounjaro 7.5 mg/0.5 mL pen 0.5 mL. The contract has an ultimate completion date of April 7, 2025 and is a firm fixed-price delivery order. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $6,128.89. The contract is for the procurement of the medication Mounjaro 7.5 mg/0.5 ml pen, a 0.5 ml dose. It is a firm fixed-price contract with a period of performance through March 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,447.12, is a delivery order to supply the medication Mounjaro (5 mg/0.5 ml pen) for the DLA. The contract has a ceiling value of $5,447.12 and a period of performance through February 28, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the medication Mounjaro 7.5 mg/0.5 ml pen. The award is a firm fixed-price contract with a ceiling value of $3,277.16 and a period of performance through April 17, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. This contract is part of a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,632.54, is for the delivery of the medication Mounjaro 15 mg/0.5 ml pen 0.5 ml. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price contract. AmerisourceBergen is the prime contractor, and there is no set-aside designation indicated. This...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,572.11, is for the delivery of the medication Mounjaro 5 mg/0.5 ml pen 0.5 ml. The contract is a firm fixed-price delivery order with a period of performance through May 22, 2025. The contract is not set-aside and was awarded on an open competition basis. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,699.29, is for the delivery of the drug Mounjaro 7.5 mg/0.5 ml pen. The contract is a Firm Fixed Price Delivery Order with a completion date of January 28, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,360.45, is a delivery order for the supply of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of January 7, 2025 and is a firm fixed price contract. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award. The...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,999.17, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a medication used in the treatment of various medical conditions. The contract has a completion date of January 15, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. AmerisourceBergen...